EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives

Jonathan Calvello, Michael Avaricio, Paolo Ruggeri, Antonio M Esquinas, Bushra Mina

Seminars in Respiratory and Critical Care Medicine · 01.06.2026 · 47 (03) · 298-307

DOI: 10.1055/a-2826-5752 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, erschienen am 01.06.2026. Verfasst von Jonathan Calvello und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Northwell Northern Westchester Hospital, New York, United States. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are major drivers of morbidity, mortality, disease progression, and healthcare utilization worldwide. Evolving definitions of COPD and exacerbations, along with emerging evidence on risk stratification and treatment optimization, have prompted updates in clinical practice, most recently reflected in the 2026 Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. This review summarizes contemporary perspectives on AECOPD, with a focus on updated definitions, epidemiology, predictors, clinical impact, and current pharmacological and nonpharmacological management strategies, including emerging preventive therapies. A narrative review of published literature, international guidelines, and major clinical trials was conducted, emphasizing evidence relevant to the assessment, treatment, and prevention of AECOPD. Particular attention was given to severity classification and guideline-directed therapeutic approaches. AECOPD is associated with substantial short- and long-term mortality, accelerated lung function decline, increased cardiovascular risk, and high readmission rates. The 2026 GOLD guidelines lower the threshold for high-risk classification, recognizing that even a single moderate exacerbation increases future risk. Acute management remains centered on short-acting bronchodilators, short courses of systemic corticosteroids, and antibiotics when indicated, with treatment of intensity guided by clinical severity and physiological derangements. Adjunctive supportive measures and early postdischarge interventions are critical to improving outcomes. While biologics, macrolides, Roflumilast, and Ensifentrine have no established role in the acute setting, they play an important role in exacerbation prevention as part of individualized, biomarker-informed maintenance strategies. AECOPD should be viewed as a sentinel event that necessitates both effective acute management and reassessment of long-term therapy. Early intervention, severity-based treatment, and postexacerbation optimization of maintenance therapy are essential to reduce recurrence, limit disease progression, and improve survival and quality of life in patients with COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveHumansDisease ProgressionPractice Guidelines as TopicBronchodilator AgentsAnti-Bacterial AgentsAdrenal Cortex HormonesSeverity of Illness IndexAcute Disease

Substanzen

Bronchodilator AgentsAnti-Bacterial AgentsAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Medicine, Northwell Northern Westchester Hospital, New York, United States.
  • Division of Pulmonary Medicine, Department of Biomedical Sciences, Dental Sciences & Morpho-Functional Imaging, University of Messina, Messina, Italy.
  • Intensive Care Unit, Hospital Morales Meseguer, NIV-ICU Group, Biomedical Research Institute Pascual Parrilla-IMIB, Murcia, Spain.
  • Division, Pulmonary Critical Care and Sleep Medicine, Department of Medicine, Northwell Northern Westchester Hospital, New York, United States.

Zitieren

APA

Calvello, J., Avaricio, M., Ruggeri, P., Esquinas, A. M., & Mina, B. (2026). Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives. Seminars in Respiratory and Critical Care Medicine, 47(03), 298-307. https://doi.org/10.1055/a-2826-5752

Vancouver

Calvello J, Avaricio M, Ruggeri P, Esquinas AM, Mina B. Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives. Seminars in Respiratory and Critical Care Medicine. 2026;47(03):298-307. doi:10.1055/a-2826-5752

BibTeX
@article{Calvello2026,
  author = {Calvello, Jonathan and Avaricio, Michael and Ruggeri, Paolo and Esquinas, Antonio M and Mina, Bushra},
  title = {Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives},
  journal = {Seminars in Respiratory and Critical Care Medicine},
  year = {2026},
  volume = {47},
  number = {03},
  pages = {298--307},
  doi = {10.1055/a-2826-5752}
}
Kostenlos starten →